Clinical Trials Contact

About this Clinical Trial

A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

All fields are required. *

Preferred contact method*

Thank you for your message about A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc). You must verify your email address to receive further communication about this trial. Please check your email for a verification message.


Continue to explore Clinical Trials

Didn't receive an email verification message? You can wait a few minutes or submit another form.

Submit another form

We were not able to send your contact info at this time.

Continue to explore Clinical Trials

We're sorry, your verification code has expired. Please submit another form using the button below to receive communications about your preferred clinical trial study.

Submit a new form

Clinical Trial Study Email Verified A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of Riociguat in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Continue to explore Clinical Trials